Patents by Inventor John F. Moeller
John F. Moeller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11994275Abstract: A site light including a body, the body including a base, and a handle assembly spaced a distance from the base to at least partially define a housing volume therebetween. The site light also including an arm, the arm having a first end fixedly coupled to the body and a second end opposite the first end to define an arm length therebetween, where the second end of the arm is movable relative to the body to adjust the arm length, and the site light including a light assembly coupled to and movable together with the second end of the arm relative to the body, and where the light assembly is adjustable between a stowed position in which at least a portion of the light assembly is positioned within the housing volume, and a second position, in which the light assembly is positioned outside the housing volume.Type: GrantFiled: August 25, 2022Date of Patent: May 28, 2024Assignee: MILWAUKEE ELECTRIC TOOL CORPORATIONInventors: David Proeber, Ross McIntyre, Jason D. Thurner, Michael A. Verhagen, Gareth Mueckl, Brian Cornell, Dalton F. Hansen, Anthony R. Sleck, John S. Scott, Scott T. Moeller
-
Publication number: 20240165314Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: ApplicationFiled: December 26, 2023Publication date: May 23, 2024Applicant: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 11946625Abstract: A site light including a body, an arm coupled to the body having an adjustable arm length, a light assembly coupled to the arm opposite the body, and a drive assembly configured to alter the arm length. The drive assembly, in turn, includes a drive wheel mounted for rotation with respect to the body, an idle wheel mounted for rotation with respect to the body, and a biasing member configured to bias the idle wheel toward the drive wheel. The site light also includes a cable coupled to the arm where the cable is positioned between and engaged by both the drive wheel and the idle wheel.Type: GrantFiled: October 30, 2020Date of Patent: April 2, 2024Assignee: MILWAUKEE ELECTRIC TOOL CORPORATIONInventors: David Proeber, Ross McIntyre, Jason D. Thurner, Michael A. Verhagen, Gareth Mueckl, Brian Cornell, Dalton F. Hansen, Anthony R. Sleck, John S. Scott, Scott T. Moeller
-
Publication number: 20240100090Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.Type: ApplicationFiled: October 30, 2023Publication date: March 28, 2024Applicant: Immutrix Therapeutics, Inc.Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 11918728Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: GrantFiled: November 6, 2020Date of Patent: March 5, 2024Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller, Jose A. Diaz-Aunon
-
Patent number: 11896753Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: GrantFiled: March 3, 2020Date of Patent: February 13, 2024Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 11839628Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.Type: GrantFiled: March 26, 2021Date of Patent: December 12, 2023Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Publication number: 20230372596Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is in a range from about 0.1:100 to 100:0.1 to produce a third filtrate.Type: ApplicationFiled: August 3, 2023Publication date: November 23, 2023Applicant: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 11759561Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: GrantFiled: September 1, 2020Date of Patent: September 19, 2023Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Publication number: 20220152524Abstract: A method of preparing a universal blood product comprising obtaining a blood product; contacting the blood product with (i) hydroxyapatite; (ii) a carbonaceous material comprising at least a mixture of a first carbon particle having macroporous size ? and a second carbon particle having macroporous size ?; and (iii) at least one support matrix chemically associated with an antigenic determinant.to form a cleansed product; and recovering the cleansed product.Type: ApplicationFiled: January 6, 2022Publication date: May 19, 2022Applicant: Proprietary Technology Assets, LLCInventors: Carol A. Rae, Jan S. Simoni, John F. Moeller
-
Patent number: 11253794Abstract: A method of preparing a universal blood product comprising obtaining a blood product; contacting the blood product with (i) hydroxyapatite; (ii) a carbonaceous material comprising at least a mixture of a first carbon particle having macroporous size ? and a second carbon particle having macroporous size ?; and (iii) at least one support matrix chemically associated with an antigenic determinant. to form a cleansed product; and recovering the cleansed product. A method of preparing a universal blood product comprising obtaining a blood product; contacting the blood product with (i) hydroxyapatite; (ii) a carbonaceous material comprising at least a mixture of a first carbon particle having macroporous size ? and a second carbon particle having macroporous size ?; and (iii) at least one support matrix chemically associated with an antigenic determinant. to form a cleansed product; wherein at least one of the hydroxyapatite, carbonaceous material and support matrix is functionalized.Type: GrantFiled: May 27, 2016Date of Patent: February 22, 2022Assignee: Proprietary Technology Assets, LLCInventors: Carol A. Rae, Jan S. Simoni, John F. Moeller
-
Publication number: 20210236543Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.Type: ApplicationFiled: March 26, 2021Publication date: August 5, 2021Applicant: IMMUTRIX THERAPEUTICS, INC.Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 10960022Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.Type: GrantFiled: October 16, 2018Date of Patent: March 30, 2021Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Publication number: 20210052803Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: ApplicationFiled: November 6, 2020Publication date: February 25, 2021Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller, Jose A. Diaz-Aunon
-
Publication number: 20200397973Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: ApplicationFiled: September 1, 2020Publication date: December 24, 2020Applicant: ImMutriX Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 10773011Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: GrantFiled: May 2, 2017Date of Patent: September 15, 2020Assignee: Immutrix Therapeutics, Inc.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Publication number: 20200197598Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: ApplicationFiled: March 3, 2020Publication date: June 25, 2020Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Patent number: 10617813Abstract: A method comprising obtaining a bodily fluid from a subject; contacting the bodily fluid with an adsorbent material comprising a synthetic carbon particle (SCP) to produce a first filtrate having a level of disease mediators (y); contacting the first filtrate with an adsorbent material comprising the SCP and an anion exchange resin where the ratio of SCP to anion exchange resin is from about 0.1:100 to 100:0.1 to produce a second filtrate; contacting the second filtrate with an adsorbent material comprising the SCP and a cation exchange resin where the ratio of SCP to cation exchange resin is from about 1:100 to produce a third filtrate; and administering the third filtrate to the subject.Type: GrantFiled: November 18, 2015Date of Patent: April 14, 2020Assignee: IMMUTRIX THERAPEUTICS, INC.Inventors: Carol A. Rae, Jan Simoni, Grace Simoni, John F. Moeller
-
Publication number: 20190105631Abstract: A three-component composition for use in the treatment of preeclampsia and related disorders wherein a first component comprises a bimodal synthetic carbon particle mixture; a second component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor sEndoglin and a third component comprises a resin bead with at least one affinity ligand directed toward syncytiotrophoblast-derived factor soluble Fms-like tyrosine kinase-1.Type: ApplicationFiled: March 31, 2017Publication date: April 11, 2019Inventors: Carol A. Rae, Jan Simoni, John F. Moeller
-
Publication number: 20190046567Abstract: A three component composition for use in the treatment of an autoimmune disease where the first component comprises a bimodal synthetic carbon particle mixture; the second component comprises a bimodal synthetic carbon particle mixture and an anion exchange resin and the third component comprises a bimodal synthetic carbon particle mixture and a cation exchange resin.Type: ApplicationFiled: October 16, 2018Publication date: February 14, 2019Inventors: Carol A Rae, Jan Simoni, Grace Simoni, John F. Moeller